Literature DB >> 15297036

D-serine-induced nephrotoxicity: possible interaction with tyrosine metabolism.

R E Williams1, E A Lock.   

Abstract

D-serine selectively damages renal proximal tubule cells in rats by a mechanism that is not fully understood. Recent proteomic analysis identified that D-serine elevated plasma fumarylacetoacetate hydrolase (FAH). FAH is involved in tyrosine catabolism; hence, this pathway may be involved in mediating the toxicity. This work examines whether 2-(2-nitro-4-trifluoromethylbenzoyl)-cyclohexane-1,3-dione (NTBC), a potent inhibitor of the enzyme 4-hydroxyphenylpyruvate dioxygenase (HPPD) located upstream of FAH, modulates D-serine-induced nephrotoxicity. Rats were pretreated with NTBC (0.5 mg/kg p.o.) or corn oil and then 30 min later given either D-serine (250 mg/kg i.p.) or water. Urine was collected every 12 h until termination (48 h) and analysed by 1H NMR spectroscopy and principal component analysis (PCA). Markers of proximal tubule injury were evident in urine following treatment with D-serine and NTBC + D-serine. PCA could not distinguish between these urine samples suggesting that NTBC does not effect the development of nephrotoxicity. Clinical chemistry analysis of urine and terminal plasma samples and histopathological examination of the kidneys confirmed this. NTBC alone caused a marked increase in the excretion of 4-hydroxyphenylpyruvate (HPPA) and 4-hydroxyphenyllactate (HPLA); however, HPPA and HPLA excretion was minimal following NTBC + D-serine. Instead marked tyrosinuria was observed suggesting that D-serine-induced renal damage markedly affects the handling of increased levels of HPPA and HPLA resulting from the inhibition of HPPD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15297036     DOI: 10.1016/j.tox.2004.05.001

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  8 in total

1.  Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury.

Authors:  Yan Yu; Hong Jin; Daniel Holder; Josef S Ozer; Stephanie Villarreal; Paul Shughrue; Shu Shi; David J Figueroa; Holly Clouse; Ming Su; Nagaraja Muniappa; Sean P Troth; Wendy Bailey; John Seng; Amy G Aslamkhan; Douglas Thudium; Frank D Sistare; David L Gerhold
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

Review 2.  Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.

Authors:  Alfred H Merrill
Journal:  Chem Rev       Date:  2011-09-26       Impact factor: 60.622

Review 3.  Application of metabonomic analytical techniques in the modernization and toxicology research of traditional Chinese medicine.

Authors:  Yong-Min Lao; Jian-Guo Jiang; Lu Yan
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

4.  The glycine site of NMDA receptors--a target for treatment of schizophrenia.

Authors:  Joachim F Hallmayer
Journal:  Curr Psychiatry Rep       Date:  2006-06       Impact factor: 5.285

5.  Modulating NMDA Receptor Function with D-Amino Acid Oxidase Inhibitors: Understanding Functional Activity in PCP-Treated Mouse Model.

Authors:  Henry Sershen; Audrey Hashim; David S Dunlop; Raymond F Suckow; Tom B Cooper; Daniel C Javitt
Journal:  Neurochem Res       Date:  2016-02-08       Impact factor: 3.996

6.  Contribution of the d-Serine-Dependent Pathway to the Cellular Mechanisms Underlying Cognitive Aging.

Authors:  B Potier; F R Turpin; P-M Sinet; E Rouaud; J-P Mothet; C Videau; J Epelbaum; P Dutar; J-M Billard
Journal:  Front Aging Neurosci       Date:  2010-02-05       Impact factor: 5.750

Review 7.  D-serine signalling as a prominent determinant of neuronal-glial dialogue in the healthy and diseased brain.

Authors:  J-M Billard
Journal:  J Cell Mol Med       Date:  2008-03-20       Impact factor: 5.310

Review 8.  The role of D-serine as co-agonist of NMDA receptors in the nucleus accumbens: relevance to cocaine addiction.

Authors:  Marcello D'Ascenzo; Maria Vittoria Podda; Claudio Grassi
Journal:  Front Synaptic Neurosci       Date:  2014-07-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.